To confirm cancer-cell content in our low-volume primary tissue specimen, we have developed a multiplex epigenetic biomarker assay to detect promoter methylation of PC-associated genes including GSTP1, RASSF1, RARb and APC [27–31]. Here, RASSF1 is linked to pachyonychia congenita.